Belgium· BE-AMP-SAM589395-00

Evrenzo 150 mg

A roxadustat product containing roxadustat, registered in Belgium by Astellas Pharma Europe. The same ATC class is registered in 13 of our 19 countries.

ATC B03XA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEvrenzo 150 mgATCB03XA05REGISTER NO.BE-AMP-SAM589395-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Roxadustat is registered in 13 of 19 countries.

Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Roxadustat · ATC B03XA05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of roxadustat costs, country by country.

Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Roxadustat · price per daily dose (43 mg)

USD · FX 28 Sept 2026

  • FR France$77.81
  • IT Italy$23.73
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Roxadustat
Manufacturer
Astellas Pharma Europe
Country
Belgium (BE)
ATC code
B03XA05
ATC class
Roxadustat
Defined daily dose
43 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    4386983
    EUR 328.22
  • be_apb
    7739253

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Roxadustat in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All roxadustat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Evrenzo
  • Liechtenstein · Evrenzo
  • Norway · Evrenzo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6606bb5-a5de-489f-9491-0041f3e8d8fa
GET /v1/drugs/c6606bb5-a5de-489f-9491-0041f3e8d8fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Evrenzo 150 mg",
  "name_fr": "Evrenzo 150 mg",
  "name_nl": "Evrenzo 150 mg",
  "amp_code": "SAM589395-00",
  "strengths": [
    "150.0000",
    "150.0000",
    "303.5000"
  ],
  "pack_count": 2,
  "substances": [
    "Roxadustat",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Roxadustat",
  "authorisation_numbers": [
    "EU/1/21/1574/005",
    "EU/1/21/1574/010"
  ]
}

See everything about roxadustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.